Literature DB >> 7625820

Results of German multicenter study of antimicrobial susceptibilities of Trichophyton rubrum and Trichophyton mentagrophytes strains causing tinea unguium. German Collaborative Dermatophyte Drug Susceptibility Study Group.

H C Korting1, M Ollert, D Abeck.   

Abstract

Thirty-two strains of Trichophyton rubrum and 16 strains of Trichophyton mentagrophytes isolated from patients with tinea unguium in various parts of Germany were subjected to a microdilution test with six systemic or topical antimycotic agents. Apart from griseofulvin, there were no species-specific differences between the two species. Terbinafine was the most active antimycotic agent, with a MIC not exceeding 0.05 micrograms/ml.

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7625820      PMCID： PMC162715          DOI： 10.1128/AAC.39.5.1206

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  16 in total

1.  Molluscum contagiosum; a marker for advanced HIV infection.

Authors:  R J Koopman; F C van Merriënboer; S G Vreden; W M Dolmans
Journal:  Br J Dermatol       Date:  1992-05       Impact factor: 9.302

Review 2.  Antifungal susceptibility testing with dermatophytes.

Authors:  A Georgii; H C Korting
Journal:  Mycoses       Date:  1991 May-Jun       Impact factor: 4.377

3.  [Isolation and identification of dermatophytes].

Authors:  W Meinhof
Journal:  Zentralbl Bakteriol       Date:  1990-06

4.  Griseofulvin-resistant dermatophytosis correlates with in vitro resistance.

Authors:  W M Artis; B M Odle; H E Jones
Journal:  Arch Dermatol       Date:  1981-01

5.  Antimycotic susceptibility testing of dermatophytes in microcultures with a standardized fragmented mycelial inoculum.

Authors:  T C Granade; W M Artis
Journal:  Antimicrob Agents Chemother       Date:  1980-04       Impact factor: 5.191

Review 6.  Itraconazole. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in superficial and systemic mycoses.

Authors:  S M Grant; S P Clissold
Journal:  Drugs       Date:  1989-03       Impact factor: 9.546

7.  In vitro susceptibility of dermatophytes from Munich to griseofulvin, miconazole and ketoconazole.

Authors:  H C Korting; S Rosenkranz
Journal:  Mycoses       Date:  1990-03       Impact factor: 4.377

8.  Antifungal activity of the allylamine derivative terbinafine in vitro.

Authors:  G Petranyi; J G Meingassner; H Mieth
Journal:  Antimicrob Agents Chemother       Date:  1987-09       Impact factor: 5.191

9.  Virulence of Candida albicans mutants.

Authors:  A Polak
Journal:  Mycoses       Date:  1992 Jan-Feb       Impact factor: 4.377

Review 10.  Is tinea unguium still widely incurable? A review three decades after the introduction of griseofulvin.

Authors:  H C Korting; M Schäfer-Korting
Journal:  Arch Dermatol       Date:  1992-02
View more
  17 in total

Review 1.  Antifungal susceptibility testing: practical aspects and current challenges.

Authors:  J H Rex; M A Pfaller; T J Walsh; V Chaturvedi; A Espinel-Ingroff; M A Ghannoum; L L Gosey; F C Odds; M G Rinaldi; D J Sheehan; D W Warnock
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

2.  Collaborative evaluation of optimal antifungal susceptibility testing conditions for dermatophytes.

Authors:  Belkys Fernández-Torres; Francisco J Cabañes; Alfonso J Carrillo-Muñoz; Alexandre Esteban; Isabel Inza; Lourdes Abarca; Josep Guarro
Journal:  J Clin Microbiol       Date:  2002-11       Impact factor: 5.948

3.  Use of the sensititre colorimetric microdilution panel for antifungal susceptibility testing of dermatophytes.

Authors:  I Pujol; J Capilla; B Fernández-Torres; M Ortoneda; J Guarro
Journal:  J Clin Microbiol       Date:  2002-07       Impact factor: 5.948

4.  Comparison of in vitro activities of 17 antifungal drugs against a panel of 20 dermatophytes by using a microdilution assay.

Authors:  Bertrand Favre; Bettina Hofbauer; Kwang-Soo Hildering; Neil S Ryder
Journal:  J Clin Microbiol       Date:  2003-10       Impact factor: 5.948

5.  [Mycological laboratory].

Authors:  B Beifuss; C Borelli; H C Korting
Journal:  Hautarzt       Date:  2006-06       Impact factor: 0.751

Review 6.  [Conventional and molecular diagnosis of cutaneous mycoses].

Authors:  C Borelli; B Beifuss; S Borelli; M Schaller; H C Korting
Journal:  Hautarzt       Date:  2008-12       Impact factor: 0.751

7.  Evaluation of broth microdilution antifungal susceptibility testing conditions for Trichophyton rubrum.

Authors:  D A Santos; J S Hamdan
Journal:  J Clin Microbiol       Date:  2005-04       Impact factor: 5.948

8.  Comparison of the in vitro activities of newer triazoles and established antifungal agents against Trichophyton rubrum.

Authors:  Shuwen Deng; Chao Zhang; Seyedmojtaba Seyedmousavi; Shuang Zhu; Xin Tan; Yiyang Wen; Xin Huang; Wenzhi Lei; Zhaojing Zhou; Wenjie Fang; Shuaishuai Shen; Danqi Deng; Weihua Pan; Wanqing Liao
Journal:  Antimicrob Agents Chemother       Date:  2015-04-20       Impact factor: 5.191

9.  [Clotrimazole and ciclopirox olamine respectively in combination with methylprednisolone aceponate as extemporaneous formulations].

Authors:  J Wohlrab; R H H Neubert; E Sommer; J Michael
Journal:  Hautarzt       Date:  2017-04       Impact factor: 0.751

10.  In vitro activity of posaconazole against clinical isolates of dermatophytes.

Authors:  F Barchiesi; D Arzeni; V Camiletti; O Simonetti; A Cellini; A M Offidani; G Scalise
Journal:  J Clin Microbiol       Date:  2001-11       Impact factor: 5.948
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.